The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
- Status
- RECRUITING
- Phase
- PHASE2
TIME in Immunotherapy Combined With nCRT for Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
- Status
- RECRUITING
- Phase
- PHASE1
Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.
- Status
- UNKNOWN
- Phase
- PHASE2
Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
- Status
- RECRUITING
- Phase
- PHASE3
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1